Initial Statement of Beneficial Ownership (3)
October 26 2022 - 3:48PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Forminard Elizabeth |
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/17/2022
|
3. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [JNJ]
|
|
(Last)
(First)
(Middle)
ONE JOHNSON & JOHNSON PLAZA |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Executive VP, General Counsel / |
|
(Street)
NEW BRUNSWICK, NJ 08933
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 3211.0000 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Employee Stock Options (Right to Buy) (1) | 2/13/2020 | 2/13/2027 | Common Stock | 11521.0000 | $115.6700 | D | |
| Employee Stock Options (Right to Buy) (1) | 2/12/2021 | 2/11/2028 | Common Stock | 8921.0000 | $129.5100 | D | |
| Employee Stock Options (Right to Buy) (1) | 2/11/2022 | 2/11/2029 | Common Stock | 9344.0000 | $131.9400 | D | |
| Employee Stock Options (Right to Buy) (1) | 2/10/2023 | 2/10/2030 | Common Stock | 13072.0000 | $151.4100 | D | |
| Employee Stock Options (Right to Buy) (1) | 2/8/2024 | 2/8/2031 | Common Stock | 10756.0000 | $164.6200 | D | |
| Employee Stock Options (Right to Buy) (1) | 2/14/2025 | 2/14/2032 | Common Stock | 8401.0000 | $165.8900 | D | |
| Restricted Share Units (2) | 2/8/2024 | (2) | Common Stock | 979.0000 | (2) | D | |
| Restricted Share Units (2) | 2/10/2023 | (2) | Common Stock | 1022.0000 | (2) | D | |
| Restricted Share Units (2) | 2/14/2025 | (2) | Common Stock | 851.0000 | (2) | D | |
| Explanation of Responses: |
| (1) | Vested and exercisable on the third anniversary of the date of the grant. |
| (2) | Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant. |
Remarks:
forminardpoa1.txt |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Forminard Elizabeth
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933 |
|
| Executive VP, General Counsel |
|
Signatures
|
| Raavi Deol, as attorney-in-fact for Elizabeth Forminard | | 10/26/2022 |
| **Signature of Reporting Person | Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
